GreenLight Biosciences Holdings Price & Performance (GRNAW)

GreenLight Biosciences has closed an additional $25 million in Series C funding, led by Just Climate. The investment will accelerate commercialization of RNA-based crop protection products like Calantha™, now registered in the U.S. and Ukraine, and support global expansion, including new research facilities in Spain and manufacturing scale-up in New York.123

Vincerx Pharma announced it will wind down after failing to secure a merger, following previous workforce reductions. The company is now exploring asset monetization and outlicensing opportunities. This move reflects ongoing challenges in the biotech sector, with several firms restructuring or reducing staff to improve financial efficiency.4

Peloton Interactive received a stock upgrade from Canaccord Genuity, moving from 'Hold' to 'Buy' with a $10 price target. Analysts cite the company’s strong membership base and recurring revenue streams, expecting further growth through new product introductions and subscription expansion in the connected fitness market.5